A representative from the Drug Enforcement Administration (DEA) has expressed the agency’s intention to dispel any misunderstandings surrounding its drug scheduling review process, emphasizing a commitment to transparency. The DEA is currently in the process of potentially reclassifying marijuana and aims to ensure clarity in its decision-making.
Opponents of marijuana rescheduling are using a coordinated legal playbook to push court briefings into…
Six years after his last album, the artist who still can’t understand why anyone calls…
Puerto Rico’s new Act 204-2026 creates an exception to workplace protections for registered medical cannabis…
A new survey conducted in September among 1,008 U.S. adults interested in hiking and camping…
“I didn’t invent it. I described it.” Five days, no budget and 26 rounds of…
Legalization was sold as a finish line. Regulators in four states say it was the…